"Receptors, Interleukin-6" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors that are specific for INTERLEUKIN-6. They are present on T-LYMPHOCYTES, mitogen-activated B-LYMPHOCYTES, and peripheral MONOCYTES. The receptors are heterodimers of the INTERLEUKIN-6 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR GP130.
| Descriptor ID |
D019947
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.400
|
| Concept/Terms |
Receptors, Interleukin-6- Receptors, Interleukin-6
- Receptors, Interleukin 6
- IL-6 Receptors
- IL 6 Receptors
- Receptors, IL-6
- Receptors, IL 6
- IL6 Receptors
- Receptors, IL6
- Interleukin 6 Receptor
- Receptor, Interleukin 6
- Interleukin-6 Receptors
- Interleukin 6 Receptors
- IL-6 Receptor
- IL 6 Receptor
- Receptor, IL-6
- IL6 Receptor
- Receptor, IL6
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-6".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-6".
This graph shows the total number of publications written about "Receptors, Interleukin-6" by people in this website by year, and whether "Receptors, Interleukin-6" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 7 | 0 | 7 |
| 2018 | 8 | 5 | 13 |
| 2019 | 1 | 0 | 1 |
| 2020 | 17 | 31 | 48 |
| 2021 | 13 | 8 | 21 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Interleukin-6" by people in Profiles.
-
Tocilizumab, blood cells, and mild COVID-19: delayed vascular protection by interleukin blockade? Eur Heart J Cardiovasc Pharmacother. 2021 09 21; 7(5):e81-e82.
-
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. N Engl J Med. 2021 09 16; 385(12):1147.
-
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply. N Engl J Med. 2021 09 16; 385(12):1147-1149.
-
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply. N Engl J Med. 2021 09 16; 385(12):1149.
-
SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells. J Virol. 2021 08 10; 95(17):e0079421.
-
IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How? JAMA. 2021 08 10; 326(6):483-485.
-
Fast and Efficient Genome Editing of Human FOXP3+ Regulatory T Cells. Front Immunol. 2021; 12:655122.
-
Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients'. Cytokine. 2021 12; 148:155662.
-
Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms. Exp Mol Med. 2021 07; 53(7):1116-1123.
-
Toward a Coronavirus Knowledge Graph. Genes (Basel). 2021 06 29; 12(7).